1. Home
  2. ELWT vs ICCC Comparison

ELWT vs ICCC Comparison

Compare ELWT & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ELWT

Elauwit Connection Inc.

N/A

Current Price

$6.89

Market Cap

46.4M

ML Signal

N/A

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

N/A

Current Price

$6.44

Market Cap

55.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ELWT
ICCC
Founded
2002
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.4M
55.5M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
ELWT
ICCC
Price
$6.89
$6.44
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
54.6K
11.3K
Earning Date
05-15-2026
03-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.33
EPS
N/A
0.20
Revenue
N/A
$26,493,169.00
Revenue This Year
$167.76
N/A
Revenue Next Year
$22.42
N/A
P/E Ratio
N/A
$31.95
Revenue Growth
N/A
51.64
52 Week Low
$4.11
$4.52
52 Week High
$8.25
$7.60

Technical Indicators

Market Signals
Indicator
ELWT
ICCC
Relative Strength Index (RSI) 57.34 52.30
Support Level $6.11 $6.06
Resistance Level $7.05 $6.84
Average True Range (ATR) 0.71 0.19
MACD -0.05 -0.01
Stochastic Oscillator 54.56 62.87

Price Performance

Historical Comparison
ELWT
ICCC

About ELWT Elauwit Connection Inc.

Elauwit Connection Inc is a customer-centric service provider of broadband Internet networks for the multifamily and student housing property sectors across the United States. The company generates revenue from the following sources: network design and installation and internet network services. It provides service offering wholesale to REITs, property ownership groups, and property management companies, engaged in its target real estate sectors.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: